Paper56807
Evidence for hybrid formation between rubella virus and a latent virus of BHK21/WI-2 cells.
Sato M and 3 others. Virology, 1976. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evidence for hybrid formation between rubella virus and a latent virus of BHK21/WI-2 cells. Papers, record 56807. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/56807
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evidence for hybrid formation between rubella virus and a latent virus of BHK21/WI-2 cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Variation | Major topic |
| Hybridization, Genetic | Major topic |
| Rubella virus | Major topic |
| Antigens, Viral | |
| Cell Line | |
| DNA Nucleotidyltransferases | |
| RNA-Directed DNA Polymerase | |
| Temperature | |
| Virus Replication |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25,915,516 | Characterising Non-Structural Protein NS4 of African Horse Sickness Virus. | PLoS One | 2015 | https://conductscience.org/library/papers/25915516 | PubMed |
| 7,817,880 | Molecular biology of rubella virus. | Adv Virus Res | 1994 | https://conductscience.org/library/papers/7817880 | PubMed |
| 646,631 | Effect of concanavalin A on the infectivity of rubella virus and its variants. | Arch Virol | 1978 | https://conductscience.org/library/papers/646631 | PubMed |
| 626,592 | Persistent infection of primary human cell cultures with rubella variant carrying DNA Polymerase activity. | Arch Virol | 1978 | https://conductscience.org/library/papers/626592 | PubMed |
| 626,590 | Evidence for phenotypic mixing between newcastle disease virus (NDV) and a latent virus of BHK 21/WI-2 cells in the early passaged BHK21/WI-2 cells persistently infected with NDV. | Arch Virol | 1978 | https://conductscience.org/library/papers/626590 | PubMed |
| 562,143 | Persistent infection of BHK21/WI-2 cells with rubella virus and characterization of rubella variants. | Arch Virol | 1977 | https://conductscience.org/library/papers/562143 | PubMed |
| 320,944 | Rubella virus and rheumatoid arthritis. | Ann Rheum Dis | 1977 | https://conductscience.org/library/papers/320944 | PubMed |
| 193,466 | Plaque formation of herpes virus hominis type 2 and rubella virus in variants isolated from the colonies of BHK21/WI-2 cells formed in soft agar. | Arch Virol | 1977 | https://conductscience.org/library/papers/193466 | PubMed |
| 75,725 | Isolation and characterization of a new rubella variang with DNA polymerase activity. | Arch Virol | 1978 | https://conductscience.org/library/papers/75725 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/56807
GET https://conductscience.org/api/papers/v1/56807/authors